- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World

Germany's Federal Court of Justice (BGH) is set to rule on Thursday on claims by Wirecard shareholders in the insolvency of the former DAX company.
The question at issue is whether aggrieved shareholders can claim damages from the insolvency estate as ordinary creditors or not.
In this specific case, the asset management company Union Investment has filed a claim for €10 million ($11.6 million) in damages with the Wirecard insolvency administrator's list of claims.
However, the insolvency administrator considers claims from creditors such as lending banks or former employees to be priority claims. Shareholders would only be considered if there were any money left over at the end – which does not appear to be likely.
In proceedings in 2024, the Munich Higher Regional Court strengthened the rights of shareholders and ruled in an interim judgement that they can assert claims for damages as simple insolvency claims. However, there has been no top court ruling on this matter to date.
The Federal Court of Justice ruling could therefore also have far-reaching consequences for other insolvency proceedings.
All in all, there is a lot of money at stake in this case: According to court information, around 50,000 Wirecard shareholders have filed claims for damages totalling around €8.5 billion in the list of claims.
Wirecard creditors are claiming a total of €15.4 billion. However, the insolvency estate amounts to only around €650 million. It is therefore likely that creditors will only receive a very small portion of their claims.
LATEST POSTS
- 1
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access - 2
Germany and trade unions kick off tough public-sector wage talks - 3
Five killed in Israeli air strikes on tents near Khan Younis, medics say - 4
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds - 5
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
Wizz CEO: We’re going to invest $1 b. in Israeli market
US FDA approves Kura-Kyowa's blood cancer therapy
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
Peloton recalls more than 800,000 bikes after broken seat posts injure users
When does Spotify Wrapped come out? The music streamer says 'soon.'










